Cita APA (7a ed.)

Jayavaradhan, R., Pillis, D. M., Goodman, M., Zhang, F., Zhang, Y., Andreassen, P. R., & Malik, P. (2019). CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites. Nature Portfolio.

Cita Chicago Style (17a ed.)

Jayavaradhan, Rajeswari, Devin M. Pillis, Michael Goodman, Fan Zhang, Yue Zhang, Paul R. Andreassen, y Punam Malik. CRISPR-Cas9 Fusion to Dominant-negative 53BP1 Enhances HDR and Inhibits NHEJ Specifically at Cas9 Target Sites. Nature Portfolio, 2019.

Cita MLA (8a ed.)

Jayavaradhan, Rajeswari, et al. CRISPR-Cas9 Fusion to Dominant-negative 53BP1 Enhances HDR and Inhibits NHEJ Specifically at Cas9 Target Sites. Nature Portfolio, 2019.